SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stephen M. DeMoss who wrote (672)12/29/1997 8:41:00 PM
From: Michael Burry  Read Replies (2) of 2068
 
The problems with oxhp are common.
Your analysis is superficial - no malice intended.
Aetna and Oxford are two different animals in different
situations despite the surface similarities. It is not
new news what you say about Aetna and Pacificare having
"similar" probs as Oxford - but the impact is much different,
and the problems are much less serious.
We touched on this back in early-mid Dec here.

You are posting a lot - I would ask myself, why does Oxford -
an insurance company - need more capital? The reason likely is much
what I mentioned earlier - they may run into some
serious liquidity problems without it.

stocks go way up and way down
This isn't a tech stock - it's imprtant to understand the industry
and to have a good handle on how these things run their financial
houses. There is regulation here, and if its financials get much
worse it gets shut down or limited in a major way.

If you believe the HMOs will rebound (they're all beaten down)
then there are safer avenues.
JMO,
Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext